Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer

Christina Pappa; Khadra Galaal; Sarah Smyth; Robert E. Bristow; Ali S. Khashan; Mo'iad Alazzam

doi:10.1002/14651858.CD015297

Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer

Christina Pappa
, Khadra Galaal
, Sarah Smyth
, Robert E. Bristow
, Ali S. Khashan
, Mo'iad Alazzam

Oxford University Hospitals NHS Foundation Trust
Sultan Qaboos Comprehensive Cancer Centre SQCCCRC
University of California at Irvine

Research output: Contribution to journal › Article › peer-review

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the benefits and harms of secondary CRS and chemotherapy in comparison to chemotherapy alone for women with platinum-sensitive recurrent epithelial ovarian cancer.

Original language	English
Article number	CD015297
Journal	Cochrane Database of Systematic Reviews
Volume	2024
Issue number	6
DOIs	https://doi.org/10.1002/14651858.CD015297
Publication status	Published - 27 Jun 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1002/14651858.CD015297

https://hdl.handle.net/10468/16117Licence: CC BY-NC-ND

Cite this

@article{c1ac703c9fa04acbb7899eeece9fbcb6,

title = "Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer",

abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the benefits and harms of secondary CRS and chemotherapy in comparison to chemotherapy alone for women with platinum-sensitive recurrent epithelial ovarian cancer.",

author = "Christina Pappa and Khadra Galaal and Sarah Smyth and Bristow, \{Robert E.\} and Khashan, \{Ali S.\} and Mo'iad Alazzam",

note = "Publisher Copyright: Copyright {\textcopyright} 2024 The Cochrane Collaboration. Published by John Wiley \& Sons, Ltd.",

year = "2024",

month = jun,

day = "27",

doi = "10.1002/14651858.CD015297",

language = "English",

volume = "2024",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "John Wiley and Sons Ltd",

number = "6",

}

TY - JOUR

T1 - Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer

AU - Pappa, Christina

AU - Galaal, Khadra

AU - Smyth, Sarah

AU - Bristow, Robert E.

AU - Khashan, Ali S.

AU - Alazzam, Mo'iad

PY - 2024/6/27

Y1 - 2024/6/27

N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the benefits and harms of secondary CRS and chemotherapy in comparison to chemotherapy alone for women with platinum-sensitive recurrent epithelial ovarian cancer.

AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the benefits and harms of secondary CRS and chemotherapy in comparison to chemotherapy alone for women with platinum-sensitive recurrent epithelial ovarian cancer.

UR - https://www.scopus.com/pages/publications/85197154261

U2 - 10.1002/14651858.CD015297

DO - 10.1002/14651858.CD015297

M3 - Article

C2 - 38934360

AN - SCOPUS:85197154261

SN - 1469-493X

VL - 2024

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 6

M1 - CD015297

ER -

Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this